Literature DB >> 19093788

Roles of integrins in tumor angiogenesis and lymphangiogenesis.

Barbara Garmy-Susini1, Judith A Varner.   

Abstract

The lifelong dedication of Dr. Judah Folkman to understand how tumors co-opt vasculature to promote tumor growth and spread resulted in the development of an astounding body of knowledge and development of new clinical therapeutics for cancer. Angiogenesis is a critical point in the development and dissemination of most human tumors. Tumor-associated lymphangiogenesis also plays an important role in mediating tumor spread to lymph nodes. The molecular regulations of these processes are complex, and many key molecular families have been implicated in the regulation of angiogenesis and lymphangiogenesis. By regulating cell-cell and cell-matrix contacts, integrins participate in blood and lymphatic vessel growth by promoting endothelial cell migration and survival. Understanding the underlying mechanisms by which integrins promote tumor-associated blood and lymphatic vessel development might provide important modalities for the therapeutic intervention of metastatic spread. This review focuses on the role of integrins in angiogenesis and lymphangiogenesis. Integrins represent potential targets for pharmacological agents and open new avenues for the control of metastatic spread in the treatment of malignancies. This article is dedicated to the memory of Dr. Judah Folkman, an amazing and caring teacher, scientist, physician, and friend.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19093788      PMCID: PMC2837754          DOI: 10.1089/lrb.2008.1011

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  86 in total

1.  Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells.

Authors:  Yanqiu Liu; Donald R Senger
Journal:  FASEB J       Date:  2004-03       Impact factor: 5.191

Review 2.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

3.  Lymphedema and quality of life in survivors of early-stage breast cancer.

Authors:  Sarah M Beaulac; Lindsay A McNair; Thayer E Scott; Wayne W LaMorte; Maureen T Kavanah
Journal:  Arch Surg       Date:  2002-11

4.  Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice.

Authors:  Oliver Stoeltzing; Wenbiao Liu; Niels Reinmuth; Fan Fan; Graham C Parry; Alexander A Parikh; Marya F McCarty; Corazon D Bucana; Andrew P Mazar; Lee M Ellis
Journal:  Int J Cancer       Date:  2003-04-20       Impact factor: 7.396

5.  Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly.

Authors:  Shawn M Sweeney; Gloria DiLullo; Simon J Slater; José Martinez; Renato V Iozzo; Janelle L Lauer-Fields; Gregg B Fields; James D San Antonio
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

Review 6.  Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.

Authors:  Rakesh K Jain
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

7.  Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A.

Authors:  Mary C Whelan; Donald R Senger
Journal:  J Biol Chem       Date:  2002-10-23       Impact factor: 5.157

8.  The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis.

Authors:  Nancy J Boudreau; Judith A Varner
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 10.  Integrins: roles in cancer development and as treatment targets.

Authors:  H Jin; J Varner
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

View more
  32 in total

1.  Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.

Authors:  Xiao-lei Wang; Xi-mei Chen; Jian-ping Fang; Chang-qin Yang
Journal:  Acta Pharmacol Sin       Date:  2012-03-12       Impact factor: 6.150

Review 2.  Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis.

Authors:  Jennifer J Tung; Ian W Tattersall; Jan Kitajewski
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

Review 3.  The regulation of integrin function by divalent cations.

Authors:  Kun Zhang; JianFeng Chen
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

4.  Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles.

Authors:  Shiv K Gupta; Nicholas E Vlahakis
Journal:  Cell Adh Migr       Date:  2010-04-08       Impact factor: 3.405

Review 5.  Gastrointestinal cancer metastasis and lymphatic advancement.

Authors:  Kazuhide Kumagai; Kouji Shimizu; Noboru Yokoyama; Sadatsugu Aida; Takayuki Tanaka; Kennichi Yamagata
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

6.  TSC2 modulates cell adhesion and migration via integrin-α1β1.

Authors:  Lyn M Moir; Judith L Black; Vera P Krymskaya
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-24       Impact factor: 5.464

Review 7.  Glycobiology of ocular angiogenesis.

Authors:  Anna I Markowska; Zhiyi Cao; Noorjahan Panjwani
Journal:  Glycobiology       Date:  2014-08-08       Impact factor: 4.313

Review 8.  Tissue-engineered three-dimensional tumor models to study tumor angiogenesis.

Authors:  Scott S Verbridge; Emily M Chandler; Claudia Fischbach
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

9.  Oxidized laminin-1 induces increased monocyte attachment and expression of ICAM-1 in endothelial cells.

Authors:  Elena Kostidou; Konstantina Topouridou; Angelos Daniilidis; Martha Kaloyianni; George Koliakos
Journal:  Int J Exp Pathol       Date:  2009-12       Impact factor: 1.925

10.  MVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesions.

Authors:  Amine Bazaa; Eddy Pasquier; Céline Defilles; Ines Limam; Raoudha Kessentini-Zouari; Olfa Kallech-Ziri; Assou El Battari; Diane Braguer; Mohamed El Ayeb; Naziha Marrakchi; José Luis
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.